Join the Ubrogepant group to help and get support from people like you.
Ubrogepant News
Ubrogepant Beneficial for Treating Migraine During the Prodrome
WEDNESDAY, Nov. 22, 2023 – Ubrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet. David W. Dodick, M.D.,...
FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine
DUBLIN, Dec. 23, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Ubrelvy (ubrogepant) for...
Ask a question
To post your own question to this support group, sign in or create an account.